Veeco Instruments
VECO
53.53
-2.14
-3.84%
Veeco Instruments
US · VECO
#2394 by market cap
Listed 1970
53.53
-2.14
-3.84%
Live - 5344 symbols - heartbeat 488s ago
· 2026-10-08 07:02
Pre-market
52.39
-2.13%
After-hours
53.24
-0.54%
Overnight
53.31
-0.41%
- Market cap
- 3.27B
- P/E (TTM)i
- 144.68
- P/Bi
- 3.62
- EPSi
- 0.59
- Div yieldi
- 0.00%
- 52W posi
- 45%
Reader sentiment
Are you bullish or bearish on VECO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.23, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -7.39% YoY
Margins
- Gross margin
- 39.95%
- Operating margin
- 6.72%
- Net margin
- 5.38%
Key ratios & quality
- Enterprise valuei
- 3.11B
- Altman Z-Scorei
- 5.23
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 542.08M | 419.35M | 454.16M | 583.28M | 646.14M | 666.44M | 717.30M | 664.29M |
| Gross profit | 193.72M | 158.19M | 194.30M | 242.27M | 263.15M | 285.06M | 304.01M | 265.41M |
| Selling & admin expenses | 92.06M | 79.75M | 76.25M | 84.54M | 88.95M | 92.76M | 99.66M | 98.91M |
| Research & development | 97.76M | 90.56M | 78.99M | 88.68M | 103.57M | 112.85M | 124.51M | 119.64M |
| Operating profit | -28.82M | -29.16M | 23.94M | 56.71M | 60.30M | 69.94M | 95.11M | 44.62M |
| Pretax profit | -433.83M | -77.96M | -8.46M | 25.68M | 50.99M | -28.34M | 68.83M | 39.39M |
| Tax | -26.75M | 777.00K | -73.00K | -358.00K | -115.96M | 2.03M | -4.88M | 4.00M |
| Net profit | -407.09M | -78.73M | -8.39M | 26.04M | 166.94M | -30.37M | 73.71M | 35.39M |
| Basic EPS | -9 | -2 | 0 | 1 | 3 | -1 | 1 | 1 |
| Diluted EPS | -8.63 | -1.66 | -0.17 | 0.49 | 2.71 | -0.56 | 1.23 | 0.59 |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|
| Revenue | 182.13M | 167.29M | 166.10M | 165.88M | 165.02M | 158.34M |
| Gross profit | 73.99M | 68.47M | 68.73M | 67.70M | 60.51M | 55.83M |
| Selling & admin expenses | 25.08M | 25.03M | 23.93M | 27.26M | 22.69M | 26.02M |
| Research & development | 30.95M | 28.51M | 31.56M | 28.99M | 30.58M | 29.88M |
| Operating profit | 32.01M | 14.15M | 12.37M | 10.55M | 7.54M | -646.00K |
| Pretax profit | 4.36M | 14.98M | 12.62M | 11.88M | -94.00K | -1.48M |
| Tax | -10.61M | 3.04M | 889.00K | 1.28M | -1.21M | -1.16M |
| Net profit | 14.97M | 11.95M | 11.73M | 10.60M | 1.11M | -324.00K |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.26 | 0.20 | 0.20 | 0.17 | 0.02 | -0.01 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 520.08M | 475.88M | 586.93M | 549.39M | 668.90M | 706.28M | 764.53M | 845.34M |
| Cash & ST investments | 260.46M | 244.55M | 319.40M | 223.93M | 302.41M | 305.45M | 344.31M | 390.23M |
| Inventory | 156.31M | 133.07M | 145.91M | 170.86M | 206.91M | 237.64M | 246.74M | 275.30M |
| Total assets | 900.82M | 818.09M | 898.06M | 898.98M | 1.13B | 1.23B | 1.25B | 1.33B |
| Total current liabilities | 160.05M | 118.22M | 146.68M | 189.20M | 257.90M | 218.03M | 192.28M | 178.06M |
| Short-term debt | -- | 4.20M | 4.15M | 4.44M | 23.50M | 4.03M | 30.25M | 4.16M |
| Long-term debt | 287.39M | 300.07M | 321.12M | 229.44M | 254.49M | 274.94M | 249.70M | 226.01M |
| Total liabilities | 463,041,000.00 | 443,576,000.00 | 489,690,000.00 | 461,348,000.00 | 550,359,000.00 | 556,599,000.00 | 480,807,000.00 | 440,286,000.00 |
| Total equity | 437.78M | 374.51M | 408.37M | 437.63M | 577.82M | 672.44M | 770.77M | 885.51M |
| Retained earnings | -619.98M | -698.93M | -707.32M | -681.28M | -501.80M | -532.17M | -458.46M | -423.07M |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|
| Total current assets | 764.53M | 794.81M | 791.89M | 810.33M | 845.34M | 873.42M |
| Cash & ST investments | 344.31M | 353.29M | 354.79M | 369.32M | 390.23M | 383.33M |
| Inventory | 246.74M | 254.05M | 258.98M | 263.31M | 275.30M | 282.23M |
| Total assets | 1.25B | 1.28B | 1.27B | 1.29B | 1.33B | 1.35B |
| Total current liabilities | 192.28M | 178.86M | 155.24M | 151.19M | 178.06M | 206.69M |
| Short-term debt | 30.25M | 3.81M | 3.92M | 4.06M | 4.16M | 4.10M |
| Long-term debt | 249.70M | 249.96M | 225.44M | 225.72M | 226.01M | 226.25M |
| Total liabilities | 480,807,000.00 | 466,966,000.00 | 418,509,000.00 | 413,941,000.00 | 440,286,000.00 | 469,307,000.00 |
| Total equity | 770.77M | 811.86M | 856.20M | 875.97M | 885.51M | 883.66M |
| Retained earnings | -458.46M | -446.51M | -434.78M | -424.18M | -423.07M | -423.39M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -37.74M | -7.42M | 43.02M | 67.74M | 108.48M | 61.67M | 63.82M | 69.49M |
| Depreciation & amortization | 50.00M | 34.40M | 30.70M | 26.06M | 25.65M | 24.97M | 25.14M | 20.02M |
| Free cash flow | -50.39M | -18.29M | 36.22M | 27.10M | 83.88M | 33.74M | 45.70M | 53.29M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -11.46M | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 213.08M | 129.95M | 130.28M | 120.47M | 155.47M | 159.12M | 145.82M | 163.47M |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|
| Operating cash flow | 28.39M | 19.99M | 9.04M | 15.53M | 24.93M | 7.94M |
| Depreciation & amortization | 5.98M | 5.04M | 5.10M | 4.90M | 4.98M | 5.04M |
| Free cash flow | 23.21M | 13.24M | 5.45M | 12.96M | 21.65M | 2.83M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 145.82M | 175.07M | 188.99M | 193.22M | 163.47M | 179.54M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -63.68 | -19.39 | -2.14 | 6.16 | 35.01 | -4.86 | 10.50 | 4.32 |
| ROA %i | -35.58 | -9.16 | -0.98 | 2.90 | 17.54 | -2.58 | 6.11 | 2.78 |
| ROIC %i | -42.34 | -9.31 | 2.04 | 6.24 | 23.23 | -3.14 | 7.19 | 2.86 |
| 5-year avg ROE %i | -20.55 | -22.66 | -22.21 | -17.25 | -8.81 | 2.96 | 8.93 | 10.23 |
| EBIT margin %i | -76.06 | -13.32 | 3.58 | 9.26 | 9.67 | -2.49 | 11.14 | 7.30 |
| FCF / sales %i | -- | -- | 7.97 | 4.65 | 12.98 | 5.06 | 6.37 | 8.02 |
| Current ratioi | 3.25 | 4.03 | 4.00 | 2.90 | 2.59 | 3.24 | 3.98 | 4.75 |
| Quick ratioi | 2.11 | 2.67 | 2.87 | 1.86 | 1.72 | 1.99 | 2.49 | 3.01 |
| Debt / assetsi | 31.90 | 38.45 | 36.92 | 29.67 | 27.62 | 25.26 | 25.11 | 19.76 |
| LT debt / equityi | 65.65 | 82.87 | 80.18 | 59.93 | 49.85 | 45.58 | 36.85 | 29.12 |
| Interest coveragei | -19.16 | -2.53 | 0.66 | 1.91 | 5.43 | -1.41 | 7.23 | 5.31 |
| Revenue CAGR (3Y) %i | 4.35 | 8.13 | -1.53 | 2.47 | 15.50 | 13.64 | 7.14 | 0.93 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | 41.46 | -40.37 |
| FCF CAGR (3Y) %i | -- | -- | 50.05 | -- | -- | -2.33 | 19.03 | -14.03 |
| Line item | 2024-12 | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 |
|---|---|---|---|---|---|---|
| ROE %i | 10.50 | 8.75 | 7.89 | 6.18 | 4.32 | 2.74 |
| ROA %i | 6.11 | 5.22 | 4.94 | 3.91 | 2.78 | 1.77 |
| ROIC %i | 7.19 | 6.11 | 5.59 | 4.31 | 2.86 | 1.82 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 11.14 | 10.14 | 9.58 | 7.86 | 7.30 | 4.83 |
| FCF / sales %i | 6.37 | 7.83 | 7.93 | 8.05 | 8.02 | 6.54 |
| Current ratioi | 3.98 | 4.44 | 5.10 | 5.36 | 4.75 | 4.23 |
| Quick ratioi | 2.49 | 2.80 | 3.21 | 3.42 | 3.01 | 2.69 |
| Debt / assetsi | 25.11 | 22.48 | 20.61 | 20.34 | 19.76 | 19.33 |
| LT debt / equityi | 36.85 | 34.94 | 30.23 | 29.50 | 29.12 | 29.13 |
| Interest coveragei | 7.23 | 6.59 | 6.41 | 5.50 | 5.31 | 3.63 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Development, manufacture, sales, and support of semiconductor and thin film process equipment100.00%
Quote time 2026-10-08 07:02:48 · For reference only, not investment advice and not tailored to your situation.